Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
10.75 -0.30 / -2.71%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.75 0.00 / 0.00%
 
Volume: 22.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues71.5M81.2M148.9M200.7M
 
 
 
 
 
Cost of Goods Sold6.9M15.9M24.2M15.6M
 
 
 
 
 
Depreciation And Amortization15.0M14.5M14.3M12.9M
 
 
 
 
 
 
Operating ExpensesGross Income49.6M50.8M110.4M172.2M
 
 
 
 
 
General Expenses170.8M190.3M219.2M188.7M
 
 
 
 
 
Research And Development126.8M148.7M178.7M147.7M
 
 
 
 
 
Total Operating Expenses192.7M220.7M257.8M217.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-121.2M-139.5M-108.8M-16.5M
 
 
 
 
 
Extraordinary Charge-2.7M-1.7M-11.3M--
 
 
 
 
Interest Expense On Debt10.2M33.5M40.8M38.8M
 
 
 
 
 
Other Expenses-1.0M983.0K392.0K814.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-133.0M-171.4M-159.8M-54.4M
 
 
 
 
 
Income Taxes-1.0M-406.0K-2.2M-512.0K
 
 
 
 
 
Net Income-134.0M-171.9M-162.0M-53.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS112.9M114.8M115.7M126.9M
 
 
 
 
 
Shares To Calculate EPS Diluted112.9M114.8M115.7M126.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.19-$1.50-$1.40-$0.42
 
 
 
 
 
EPS Diluted-$1.19-$1.50-$1.40-$0.42